Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. UDG Healthcare plc
  6. News
  7. Summary
    UDG   IE0033024807

UDG HEALTHCARE PLC

(UDG)
  Report
Delayed Quote. Delayed London Stock Exchange - 06/22 11:35:06 am
1040 GBX   -0.48%
06/21UDG HEALTHCAREá : Form 8.3 - UDG Healthcare plc
AQ
06/21FORM 8.3 - THE VANGUARD GROUP, INC.á : UDG Healthcare plc
DJ
06/18FORM 8.3 - THE VANGUARD GROUP, INC.á : UDG Healthcare plc
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

UDG Healthcare : Private equity firm to buy UDG Healthcare in $3.7 bln deal

05/12/2021 | 02:55am EDT

LONDON, May 12 (Reuters) - Private equity firm Clayton, Dubilier & Rice (CD&R) has agreed to buy London-listed UDG Healthcare for 2.6 billion pounds ($3.7 billion), the pharmaceuticals services company said on Wednesday.

CD&R will pay 10.23 pounds in cash per share in UDG, representing a premium of 21.5% to Tuesday's close. By 0735 GMT the London-listed shares were up 22.2% at 10.30 pounds.

UDG, which has its headquarters in Dublin, specialises in healthcare advisory, communications, commercial, clinical and packaging services.

"We believe that this is an attractive offer for UDG shareholders, which secures the delivery of future value for shareholders in cash today," UDG Chairman Shane Cooke said in a statement.

UDG has two divisions - Ashfield and Sharp - and employs about 9,000 people in 29 countries.

"UDG has long established itself as a leading provider of high-value services to pharma and biotech companies globally, supported by a highly skilled workforce," said CD&R partner Eric Rouzier.

The deal is expected to be declared effective during the third quarter of 2021, subject to shareholder and regulatory approvals.

UDG also reported half-year results to the end of March, showing adjusted pretax profit up 10% at $82.4 million on revenue down 5% at $661.4 million. ($1 = 0.7074 pounds) (Editing by Louise Heavens and David Goodman)


ę Reuters 2021
All news about UDG HEALTHCARE PLC
06/21UDG HEALTHCAREá : Form 8.3 - UDG Healthcare plc
AQ
06/21FORM 8.3 - THE VANGUARD GROUP, INC.á : UDG Healthcare plc
DJ
06/18FORM 8.3 - THE VANGUARD GROUP, INC.á : UDG Healthcare plc
DJ
06/17UDG HEALTHCAREá : Form 8.3 - UDG Healthcare plc
AQ
06/16FORM 8.3 - THE VANGUARD GROUP, INC.á : UDG Healthcare plc
DJ
06/16DIMENSIONAL FUND ADVISORS LTD.á : Form 8.3 - UDG Healthcare plc - Ordinary share..
AQ
06/15INSIDER TRENDS : Endo International Insider Awarded Shares Uses Portion to Pay T..
MT
06/14FORM 8.3 - THE VANGUARD GROUP, INC.á : UDG Healthcare plc
DJ
06/10FORM 8.3 - THE VANGUARD GROUP, INC.á : UDG Healthcare plc
DJ
06/08UDG HEALTHCAREá : Form 8.3 - UDG Healthcare plc
AQ
More news
Financials (USD)
Sales 2021 1 333 M - -
Net income 2021 107 M - -
Net Debt 2021 117 M - -
P/E ratio 2021 34,3x
Yield 2021 1,30%
Capitalization 3 655 M 3 647 M -
EV / Sales 2021 2,83x
EV / Sales 2022 2,62x
Nbr of Employees 9 000
Free-Float 95,7%
Chart UDG HEALTHCARE PLC
Duration : Period :
UDG Healthcare plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends UDG HEALTHCARE PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 14,50 $
Average target price 13,13 $
Spread / Average Target -9,47%
EPS Revisions
Managers and Directors
NameTitle
Brendan McAtamney Chief Executive Officer & Executive Director
Nigel Bernard John Clerkin Chief Financial Officer & Executive Director
Shane M. Cooke Non-Executive Chairman
Ryan Quigley Chief Operating Officer
Lisa R. Ricciardi Independent Non-Executive Director
Sector and Competitors